A recent survey reveals a significant decline in teen drug and alcohol use since 2017, reaching its lowest point in 2024. Researchers attribute this drop to pandemic lockdowns disrupting social ...

A drug dealer who was involved in an organised crime group that supplied class A drugs in Hull has been jailed for six years. Martin Southall, 43, of Easethorpe in Hull appeared at Hull Crown ...

After the FDA proposed pulling some over-the-counter cold and flu medications from shelves in the US, an Australian law firm has launched a class action ... to ensure that drugs are safe and ...

It was later found to have over £16,000 of Class A drugs inside. At Grimsby Crown Court, Robin Griffin, 37, of Alexandra Road admitted an offence of possession of Class A drugs with intent to ...

Mercedes-Benz's third-generation CLA-Class has been spotted testing The new CLA-Class will offer choice of electric and hybrid powertrains The new CLA-Class is the first member of a downsized ...

Dec 23 (Reuters) - Merck (MRK.N), opens new tab will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.

Mr. Jay is a writer based in London and the author of “Psychonauts: Drugs and the Making of the Modern Mind.” It’s becoming impossible to count all the options we have these days for ...

A class action lawsuit alleging women were improperly given a labour-inducing drug by a nurse in Moncton has been certified by New Brunswick's top court. The Court of Appeal ruled Thursday that ...

A class action has been filed against Johnson ... said it will continue to monitor the outcomes of the US Food and Drug Administration review and consultation in regards to oral phenylephrine.

A class action claim filed in the Federal Court ... of Codral Cold & Flu and Sudafed PE which contain phenylephrine, a drug the company has marketed and sold as a decongestant for years.

The trial results announced Friday are a blow to Novo’s obesity ambitions, then, disappointing analysts and investors eager for signs it can continue to dominate a drug class projected to eventually ...